This inventor holds 7 USPTO granted patents. Top assignee: Crinos Industria Farmacobiologica S.p.a.. Active years: 1992-1999.
Company Filing History:
Years Active: 1992-1999
Title: Ennio Lanzarotti: Innovator in Pharmaceutical Science
Introduction
Ennio Lanzarotti is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical science, particularly in the development of anticoagulant and antithrombotic agents. With a total of 7 patents to his name, Lanzarotti's work has the potential to impact medical treatments significantly.
Latest Patents
Lanzarotti's latest patents include innovative formulations such as "Fucans with low molecular weight having anticoagulant, antithrombinic, and antithrombotic activity." These fucan sulfates, with molecular weights ranging between 14,000 and 29,000 Dalton, exhibit remarkable anticoagulant activity in both the global coagulation mechanism and the final phase of coagulation. These compounds are also being explored for their utility as antithrombotic drugs. Another notable patent is the "Use of polydeoxyribonucleotides in diabetic neuropathies," which discloses a pharmaceutical composition comprising a polydeoxyribonucleotide of random sequence formula.
Career Highlights
Ennio Lanzarotti is associated with Crinos Industria Farmacobiologica S.p.a., where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that address critical health issues.
Collaborations
Lanzarotti collaborates with esteemed colleagues such as Armando Cedro and Giuseppe Prino, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ennio Lanzarotti's contributions to pharmaceutical science through his patents and collaborations highlight his role as a key innovator in the field. His work promises to enhance treatment options for various medical conditions, showcasing the importance of innovation in healthcare.